New Partnership Brings Mucinex Kickstart’s Fast Relief, In-Game Experiences, and High-Energy Spirit to Kings Fans This NHL Season LOS ANGELES–(BUSINESS WIRE)–Two-time Stanley Cup Champions the LA Kings and Mucinex, the #1 most trusted brand among physicians for cough and cold symptoms*, are teaming up for a game-changing partnership designating Mucinex Kickstart as the “Official Cold … [Read more…]

With backing from Peter Thiel, K5 Global, Jeff Bezos, and Wellington Management, among others, HistoSonics is positioned to expand globally across new clinical applications MINNEAPOLIS–(BUSINESS WIRE)–#Funding–HistoSonics, Inc., the developer of the Edison® Histotripsy System and novel histotripsy therapy platform, today announced the closing of an oversubscribed $250 million financing led by its new ownership group … [Read more…]

Revolutionary AI assistant RISA eliminates the pain of hunting for patient data across multiple systems, enabling clinicians to focus more on patient care SAN FRANCISCO–(BUSINESS WIRE)–ThetaRho.ai, a provider of AI-powered clinical data intelligence solutions, today announced an agreement with athenahealth, Inc. through the award-winning athenahealth® Marketplace program. Now available to athenahealth’s growing network of healthcare … [Read more…]

SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Veracyte, Inc. (Nasdaq: VCYT), a leading cancer diagnostics company, announced today that it will release financial results for the third quarter of 2025 after the close of market on Tuesday, November 4, 2025. Company management will host a conference call and webcast to discuss financial results and provide a general business … [Read more…]

Latest contract expands the Company’s state health insurance exchange market offerings to include premium billing services TYSONS, Va.–(BUSINESS WIRE)–Maximus (NYSE: MMS), a leading employer and provider of government services, today announced it has been awarded a new $31 million contract by the Massachusetts Health Connector, an independent public authority. Under the four-year base contract, Maximus … [Read more…]

OXFORD, England–(BUSINESS WIRE)–#Nanopore–At the American Society of Human Genetics (ASHG) 2025 industry session on 16th October, Oxford Nanopore Technologies will share its latest developments in enabling translational and clinical human genetics communities to deliver improved insights into mechanisms for disease in one integrated analysis. The team will highlight the unique capabilities of the PromethION in … [Read more…]

$445 million investment will support global manufacturing of Lokelma COPPELL, Texas–(BUSINESS WIRE)–AstraZeneca today announces the unveiling of its newly-expanded, state-of-the-art manufacturing facility in Coppell, Texas. The expansion project will double the production of Lokelma for the benefit of patients in the United States and around the world. The investment of $445 million to expand the … [Read more…]

Financing co-led by ARCH Venture Partners and GV (Google Ventures) to support continued advancement of PP405, a topical therapy designed to reactivate dormant hair follicle stem cells to restore hair growth Positive Phase 2a results in androgenetic alopecia support progression into Phase 3 trials in 2026 Cathy Friedman of GV has been appointed Chair of … [Read more…]

BASEL, Switzerland–(BUSINESS WIRE)–Indivi and Clouds of Care, two independent TechBio companies, today announced a strategic partnership to advance the use of precision medicine tools in early-phase neuroscience drug development, targeting Alzheimer’s and Parkinson’s disease. The field of neurodegeneration remains one of the toughest challenges in medicine, with a historically low probability of technical and regulatory … [Read more…]

BOSTON & DAEJEON, South Korea–(BUSINESS WIRE)–#ADC—Orum Therapeutics (“Orum” or the “Company”) (KRX: 475830), a public biotechnology company pioneering the field of degrader-antibody conjugates (DACs), today announced the appointment of Dorin Toader, Ph.D., as Head of Platform Technology. Dr. Toader brings more than 27 years of experience in drug discovery, including over 15 years in antibody-drug … [Read more…]